AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) – Stock analysts at Zacks Research raised their Q4 2024 earnings estimates for shares of AngioDynamics in a research note issued to investors on Tuesday, June 13th. Zacks Research analyst D. Dey now expects that the medical instruments supplier will earn $0.08 per share for the quarter, up from […]
AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) was the target of a significant growth in short interest in the month of May. As of May 31st, there was short interest totalling 888,300 shares, a growth of 16.6% from the May 15th total of 761,800 shares. Approximately 2.3% of the company’s stock are short sold. Based on […]
AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) was the target of a significant drop in short interest in May. As of May 15th, there was short interest totalling 761,800 shares, a drop of 7.1% from the April 30th total of 820,300 shares. Based on an average trading volume of 334,300 shares, the short-interest ratio is presently […]
StockNews.com assumed coverage on shares of AngioDynamics (NASDAQ:ANGO – Get Rating) in a research report report published on Thursday morning. The brokerage issued a hold rating on the medical instruments supplier’s stock. Separately, Raymond James cut AngioDynamics from a strong-buy rating to an outperform rating and decreased their target price for the stock from $14.00 […]
Heartland Advisors Inc. lifted its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) by 40.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 611,722 shares of the medical instruments supplier’s stock after purchasing an additional 175,383 shares during the quarter. […]